A Phase 1b Study to Assess the Safety and Anti-tumour Activity of Dexanabinol Monotherapy and Dexanabinol in Combination With Chemotherapy in Patients With Advanced Tumours

Trial Profile

A Phase 1b Study to Assess the Safety and Anti-tumour Activity of Dexanabinol Monotherapy and Dexanabinol in Combination With Chemotherapy in Patients With Advanced Tumours

Completed
Phase of Trial: Phase I

Latest Information Update: 12 Apr 2016

At a glance

  • Drugs Dexanabinol (Primary) ; Gemcitabine; Paclitaxel; Sorafenib
  • Indications Liver cancer; Pancreatic cancer
  • Focus Adverse reactions
  • Sponsors e-Therapeutics
  • Most Recent Events

    • 22 Mar 2016 Status changed from recruiting to completed, according to an e-Therapeutics media release.
    • 19 May 2015 The first patient has been enrolled and has received an initial dose, according to an e-Therapeutics media release.
    • 22 Apr 2015 Status changed from not yet recruiting to recruiting, as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top